Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Gets Top Billing As Novartis CEO Wields Management Broom

Executive Summary

The Swiss major has unveiled three new faces for its executive committee which include the firm's ethics head and its chief digital officer – Bertrand Bodson - who joined a couple of months ago, having implemented digital innovation and culture change in large non-pharma businesses such as Sainsbury's Argos, EMI and Amazon.

You may also be interested in...



Novartis UK Moves To London To Seek Its Life Sciences Digital Fortune

Novartis is to move its UK headquarters to London to be at the heart of the new technology and life sciences in the west of the city.

What Will Novartis Do With $13bn Cash Pile From GSK?

The Swiss major has divested a non-core asset at a decent price and its eye care unit Alcon could be next under the hammer as CEO Vas Narasimhan looks at bolt-on acquisitions to create "the leading medicines company, powered by digital and data."

Novartis Teams With Pear Therapeutics In Neurological Digital Health Pact

Duo aims to get Pear's THRIVE digital therapeutic approved, and to develop a new application to treat MS patients, then seek validation in clinical studies.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC100553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel